Last reviewed · How we verify
NCT06309420
Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts
NA trial testing Cryogenic treatment of warts (Pixie CO2) in Warts in 54 participants. Completed in 10 August 2020.
10 August 2020
Quick facts
| Lead sponsor | Oystershell NV |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 7 November 2019 |
| Primary completion | 10 August 2020 |
| Estimated completion | 10 August 2020 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Cryogenic treatment of warts (Pixie CO2)
- Cryogenic treatment of warts (Wortie®)
Conditions studied
- Warts — all drugs for Warts →
Sponsor
Oystershell NV — full company profile →
Who can join
4 and older, any sex, with Warts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study was set-up to evaluate clinical efficacy of Pixie CO2 versus a comparator product (Wortie®) for the treatment of common and plantar warts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06309420
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Warts
Currently open trials in the same condition.
- NCT07534865 — Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts · NA · recruiting
- NCT06827938 — Multicenter Real-World Study of Hyperthermia in Warts of Special Population · NA · recruiting
- NCT06812065 — Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts · NA · recruiting
- NCT05291845 — Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts · Phase 2 · recruiting
- NCT00967785 — A Phase I Study of Mozobil in the Treatment of Patients With WHIMS · Phase 1, PHASE2 · recruiting
Other Oystershell NV trials
Trials by the same sponsor.
- NCT07191457 — Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo · NA · recruiting
- NCT05378477 — A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product. · NA · unknown
- NCT04961684 — Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis · NA · completed
- NCT06309446 — Assessment of Wound Healing, Cooling Efficacy and Local Tolerability of a Wound Care Hydrogel · NA · completed
- NCT06315946 — Efficacy of a Cryogenic Medical Device on Skin Tags Versus a Comparator Product. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06309420 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oystershell NV
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06309420.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing